FDA Approves Drug to Help Cut Frequency of Cluster Headaches

by | Jun 5, 2019 | Headache Drugs | 0 comments

The U.S. Food and Drug Administration on Tuesday gave the nod to Emgality, an injected medication that’s the first to cut the frequency of cluster headaches. 6-5-19.

Read more here.

Submit a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Pin It on Pinterest